REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 2 filers reported holding REGULUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $517,000 | -70.5% | 2,614,704 | -1.5% | 0.00% | – |
| Q2 2018 | $1,750,000 | -12.4% | 2,655,259 | -4.6% | 0.00% | – |
| Q1 2018 | $1,997,000 | -22.0% | 2,784,520 | +13.2% | 0.00% | – |
| Q4 2017 | $2,559,000 | -28.7% | 2,460,729 | -14.3% | 0.00% | – |
| Q3 2017 | $3,589,000 | +147.5% | 2,870,972 | +95.3% | 0.00% | – |
| Q2 2017 | $1,450,000 | -42.4% | 1,470,364 | -3.6% | 0.00% | – |
| Q1 2017 | $2,516,000 | +64.1% | 1,524,916 | +123.7% | 0.00% | – |
| Q4 2016 | $1,533,000 | -65.3% | 681,633 | -49.0% | 0.00% | – |
| Q3 2016 | $4,413,000 | +19.5% | 1,337,145 | +4.6% | 0.00% | – |
| Q2 2016 | $3,694,000 | -54.7% | 1,278,466 | +8.7% | 0.00% | -100.0% |
| Q1 2016 | $8,149,000 | -15.4% | 1,175,887 | +6.5% | 0.00% | 0.0% |
| Q4 2015 | $9,629,000 | +43.9% | 1,104,290 | +7.9% | 0.00% | – |
| Q3 2015 | $6,691,000 | -32.3% | 1,023,066 | +13.4% | 0.00% | -100.0% |
| Q2 2015 | $9,889,000 | -31.0% | 902,252 | +6.6% | 0.00% | 0.0% |
| Q1 2015 | $14,342,000 | +17.1% | 846,660 | +10.9% | 0.00% | 0.0% |
| Q4 2014 | $12,247,000 | +279.3% | 763,562 | +61.5% | 0.00% | – |
| Q3 2014 | $3,229,000 | -11.0% | 472,740 | +4.7% | 0.00% | – |
| Q2 2014 | $3,630,000 | -4.0% | 451,485 | +7.6% | 0.00% | – |
| Q1 2014 | $3,783,000 | +110.5% | 419,451 | +72.5% | 0.00% | – |
| Q4 2013 | $1,797,000 | -16.2% | 243,138 | +6.9% | 0.00% | – |
| Q3 2013 | $2,145,000 | +201.3% | 227,462 | +213.7% | 0.00% | – |
| Q2 2013 | $712,000 | – | 72,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|